Arena Pharmaceuticals' Presence at United European Gastroenterology Week Bolsters Commitment to the Gastrointestinal Disease Community

Author's Avatar
Oct 18, 2019
Article's Main Image

- New open-label extension data from the Phase 2 OASIS trial for etrasimod in ulcerative colitis

- Arena sponsored breakfast symposium: Will oral therapies change the IBD treatment landscape?

- Visit Arena in the exhibit hall at booth #78

PR Newswire